Point72 Asia (Singapore)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Point72 Asia (Singapore)’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1	Buy	+1	New	+$1	﹤0.01%	864
2025 Q2	–	Sell	-42,877	Closed	-$63K	–	1074
2025 Q1	$63K	Buy	42,877 +34,855	+434%	+$83K	0.02%	520
2024 Q4	$35.5K	Buy	+8,022	New	+$32.5K	0.01%	569
2024 Q1	–	Sell	-4,011	Closed	-$45.9K	–	1141
2023 Q4	$45.9K	Buy	+4,011	New	+$39.7K	0.01%	322

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Point72 Asia (Singapore)'s IRWD Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in Ironwood Pharmaceuticals (IRWD) in Q3 2025: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #864 among its holdings. This is a return to the name: Point72 Asia (Singapore) previously reported a position in IRWD as recently as Q1 2025.

Point72 Asia (Singapore) first reported a position in IRWD in Q4 2023 and has held it in 4 quarters since. The position peaked at $63K in Q1 2025. 166 funds tracked by Wall St. Rank hold IRWD as of Q3 2025.

Point72 Asia (Singapore) held 1 share of Ironwood Pharmaceuticals worth $1 as of Q3 2025.
Ironwood Pharmaceuticals was a new Point72 Asia (Singapore) position in Q3 2025.
Ironwood Pharmaceuticals made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #864 holding.
Point72 Asia (Singapore) first reported a position in Ironwood Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
Point72 Asia (Singapore)'s Ironwood Pharmaceuticals position peaked at $63K in Q1 2025.
166 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.